<?xml version="1.0" encoding="UTF-8"?>
<Label drug="dovonex" track="TAC2017_ADR">
  <Text>
    <Section name="adverse reactions" id="S1">    ADVERSE REACTIONS

  In controlled clinical trials, the most frequent adverse reactions reported to be related to Dovonex  (r)  Scalp Solution, 0.005%, use were transient burning, stinging and tingling, which occurred in approximately 23% of patients. Rash was reported in about 11% of patients. Dry skin, irritation and worsening of psoriasis were reported in 1-5% of patients. Skin atrophy, hyperpigmentation, hypercalcemia, and folliculitis were not observed in these studies, but cannot be excluded.
</Section>
  </Text>
  <Mentions />
  <Relations />
  <Reactions />
</Label>
